Anzeige
Mehr »
Login
Sonntag, 29.03.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14R82 ISIN: BE0974281132 Ticker-Symbol: 8XB 
Frankfurt
27.03.20
08:17 Uhr
3,655 Euro
-0,125
-3,31 %
Branche
Gesundheitswesen
Aktienmarkt
BEL Mid
1-Jahres-Chart
BIOCARTIS GROUP NV Chart 1 Jahr
5-Tage-Chart
BIOCARTIS GROUP NV 5-Tage-Chart
RealtimeGeldBriefZeit
3,515
3,630
27.03.

Aktuelle News zur BIOCARTIS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.03.BRIEF-Biocartis Group FY Total Operating Income Up At 37.7 Million Euros4
05.03.Biocartis NV: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China13
05.03.Biocartis NV: Press Release Biocartis Group NV: Biocartis Creates New Share Option Plan & Cancels Outstanding Pool under 2018 Share Option Plan-
BIOCARTIS Aktie jetzt für 4€ handeln
05.03.Biocartis NV: Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2019 RESULTS AND 2020 OUTLOOK1
27.02.Biocartis NV: Press Release Biocartis Group NV: Biocartis to Host Webcast for Announcement 2019 Financial Results on 5 March 20201
27.01.Biocartis NV: Press release Biocartis Group: BIOCARTIS ANNOUNCES RESIGNATION CFO12
22.01.Biocartis NV: Press release Biocartis Group: Biocartis Enters into Master Collaboration Agreement with AstraZeneca and Initiates EGFR Liquid Biopsy Study8
09.01.Biocartis NV: Press Release Biocartis Group NV: Biocartis Meets 2019 Key Business Objectives11
17.12.19Biocartis NV: Press Release Biocartis Group NV: Biocartis Announces 2020 Financial Calendar1
12.12.19Press Release Biocartis NV: Disclosure of a transparency notification4
27.11.19Biocartis NV: Press news Biocartis Group NV: Disclosure of a transparency notification9
14.11.19Biocartis NV: Press release Biocartis Group NV: LISTING OF THE EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS ...4
14.11.19Biocartis NV: Press release Biocartis Group NV: NICHIREI BIOSCIENCES TO INITIATE MARKET INTRODUCTION OF IDYLLA ...5
05.11.19Press Release Biocartis NV: Five Idylla Studies to be Published at 'Association for Molecular Pathology' Annual ...1
31.10.19Biocartis NV: Press news Biocartis Group NV: Disclosure of a transparency notification1
25.10.19Press release Biocartis NV.: Biocartis Launches Liquid Biopsy Idylla ctEGFR Mutation Assay4
04.10.19Biocartis NV: Press news Biocartis Group NV: Disclosure of a transparency notification5
18.07.19Liquid Biopsy Performance Comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS Testing Published in Scientific Reports (Nature Journal)124HAMBURG, Germany, July 18, 2019 /PRNewswire/ -- Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces...
► Artikel lesen
09.04.19Biocartis Group NV: Invitation to Annual Shareholders' Meeting74PRESS RELEASE 9 April 2019, 07:00 CEST ...
► Artikel lesen
05.04.19Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES107PRESS RELEASE REGULATED INFORMATION 5 April 2019, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1